Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan

Hepatitis B virus vaccination and antiviral therapies reduce the risk of hepatocellular carcinoma (HCC). However, the lifetime healthcare expenditure involved in caring for HCC patients remains unclear. We examined the use and direct costs of healthcare services for a cohort of HCC patients to the h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Environ Res Public Health
Main Authors: Nguang, Seng-Howe, Wu, Cheng-Kun, Liang, Chih-Ming, Tai, Wei-Chen, Yang, Shih-Cheng, Ku, Ming-Kun, Yuan, Lan-Ting, Wang, Jiunn-Wei, Tseng, Kuo-Lun, Hung, Tsung-Hsing, Hsu, Pin-I, Wu, Deng-Chyang, Chuah, Seng-Kee, Hsu, Chien-Ning
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6313960/
https://ncbi.nlm.nih.gov/pubmed/30486324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph15122655
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares